Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
37.88
+0.75 (2.02%)
At close: Sep 5, 2025, 4:00 PM
37.12
-0.76 (-2.01%)
After-hours: Sep 5, 2025, 7:41 PM EDT

Apogee Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22
2,2182,5781,342-
Market Cap Growth
14.29%92.14%--
Enterprise Value
1,6081,836919-
Last Close Price
37.8745.3027.94-
PB Ratio
3.583.603.53-
P/TBV Ratio
3.583.603.53-
Debt / Equity Ratio
0.020.020.01-
Quick Ratio
16.1518.4019.3015.22
Current Ratio
16.3618.5519.3815.24
Return on Equity (ROE)
-34.12%-33.22%-32.18%-
Return on Assets (ROA)
-23.21%-23.46%-21.00%-
Return on Capital (ROIC)
-24.04%-24.41%-22.18%-
Earnings Yield
-10.72%-7.07%-6.26%-
FCF Yield
-10.22%-6.69%-5.58%-
Buyback Yield / Dilution
-17.27%-120.72%-915.57%-
Updated Aug 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q